Using a Trade-off Technique to Assess Patients' Treatment Preferences for Benign Prostatic Hyperplasia

The probability-tradeoff technique may be used to assess treatment preferences in dichotomous choices. In this feasibility study, it was used to elicit benign prostatic hyperplasia (BPH) patients' attitudes towards three different treatments. Eighty-seven male outpatients used rating scales and the standard gamble to indicate the extents to which they were free of BPH symptoms. Paired descriptions of "watchful waiting" (WW), treatment with an alpha blocker (AB), and transurethral resection of the prostate (TURP) were presented, and the probability-tradeoff technique was used to obtain treatment-preference scores. The tradeoff task identified six internally consistent pref erence-order subgroups. The majority (n = 55; 63.2%) were in the two subgroups in which TURP was the least-preferred treatment. Compared with the other respondents, the members of these two subgroups reported significantly higher utilities for their BPH symptom status (89 vs 79; t = 2.87; p < 0.0005). Within each subgroup, preference scores for the middle- and top-ranked treatments were computed relative to the bottom- ranked treatment; for both WW and AB, significant across-subgroup differences were observed. In this preliminary study the probability-tradeoff technique was feasible, able to identify unique preference-order subgroups, and able to generate apparently mean ingful preference scores in a clinical situation involving three alternative treatments. Further development of tradeoff tasks as the value-clarification component of decision aids for individual patients seems warranted. Key words: patients' preferences; deci sion aids; benign prostatic hyperplasia; utilities; probabilities; risk aversion. (Med Decis Making 1996;16:262-272)

[1]  J P Kassirer,et al.  Incorporating patients' preferences into medical decisions. , 1994, The New England journal of medicine.

[2]  A. O'Connor Validation of a Decisional Conflict Scale , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[3]  P. Schoemaker Experiments on Decisions under Risk: The Expected Utility Hypothesis , 1980 .

[4]  A. Elstein,et al.  Effects of Patient Education on Decisions about Breast Cancer Treatments , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[5]  Baruch Fischhoff,et al.  The Experienced Utility of Expected Utility Approaches , 1980 .

[6]  A. Gafni,et al.  A Bedside Decision Instrument To Elicit a Patient's Preference Concerning Adjuvant Chemotherapy for Breast Cancer , 1992, Annals of Internal Medicine.

[7]  C. Naylor,et al.  Can there be a more patient-centred approach to determining clinically important effect sizes for randomized treatment trials? , 1994, Journal of clinical epidemiology.

[8]  Graham Nichol,et al.  The Relationship between Cardiac Functional Capacity and Patients' Symptom-specific Utilities for Angina , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.

[9]  E. Metter,et al.  Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. , 1991, Urology.

[10]  T. Gasser,et al.  Controversies about indications for transurethral resection of the prostate. , 1989, The Journal of urology.

[11]  M. Barry,et al.  Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences. , 1988, JAMA.

[12]  George W. Torrance,et al.  Social preferences for health states: An empirical evaluation of three measurement techniques , 1976 .

[13]  J. Beck,et al.  A Multipurpose Interactive Videodisc with Ethical, Legal, Medical, Educational and Research Implications: The Informed Patient Decision-Making Procedure , 1989 .

[14]  D L Patrick,et al.  Methods for measuring levels of well-being for a health status index. , 1973, Health services research.

[15]  M. Holmes-Rovner Evaluation Standards for Patient Decision Supports , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[16]  Clark Rm,et al.  Patients versus surrogates: whose opinion counts on ethics review panels? , 1989 .

[17]  H. Llewellyn-Thomas,et al.  Patients versus surrogates: whose opinion counts on ethics review panels? , 1989, Clinical research.

[18]  H. Llewellyn-Thomas,et al.  Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. , 1991, Social science & medicine.

[19]  P. Clifford,et al.  Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. , 1982, The New England journal of medicine.

[20]  R. Kane,et al.  Methodology for measuring health-state preferences--II: Scaling methods. , 1989, Journal of clinical epidemiology.

[21]  C. Naylor Grey zones of clinical practice: some limits to evidence-based medicine , 1995, The Lancet.

[22]  H. Llewellyn-Thomas,et al.  Assessing Preferences about the DNR Order , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[23]  K McPherson,et al.  An assessment of prostatectomy for benign urinary tract obstruction. Geographic variations and the evaluation of medical care outcomes. , 1988, JAMA.

[24]  A. Mulley,et al.  Developing shared decision-making programs to improve the quality of health care. , 1992, QRB. Quality review bulletin.

[25]  A. O'Connor,et al.  Effects of framing and level of probability on patients' preferences for cancer chemotherapy. , 1989, Journal of clinical epidemiology.

[26]  M. Weinstein,et al.  Clinical Decision Analysis , 1980 .

[27]  H. Llewellyn-Thomas,et al.  Patients' Health-care Decision Making , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[28]  D. Hanley,et al.  Symptom status and quality of life following prostatectomy. , 1988, JAMA.

[29]  N F Boyd,et al.  Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. , 1987, Journal of chronic diseases.

[30]  P. Walsh,et al.  The development of human benign prostatic hyperplasia with age. , 1984, The Journal of urology.

[31]  P. Schoemaker The Expected Utility Model: Its Variants, Purposes, Evidence and Limitations , 1982 .

[32]  N. Feather Expectations and Actions , 2021 .